You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
Renin–Angiotensin–Aldosterone System: From History to Practice of a Secular Topic
Contributor:
Ksiazek, Sara H.;
Hu, Lilio;
Andò, Sebastiano;
Pirklbauer, Markus;
Säemann, Marcus D.;
Ruotolo, Chiara;
Zaza, Gianluigi;
La Manna, Gaetano;
De Nicola, Luca;
Mayer, Gert;
Provenzano, Michele
imprint:
MDPI AG, 2024
Published in:International Journal of Molecular Sciences
Language:
English
DOI:
10.3390/ijms25074035
ISSN:
1422-0067
Origination:
Footnote:
Description:
<jats:p>Renin–angiotensin–aldosterone system (RAAS) inhibitors are standard care in patients with hypertension, heart failure or chronic kidney disease (CKD). Although we have studied the RAAS for decades, there are still circumstances that remain unclear. In this review, we describe the evolution of the RAAS and pose the question of whether this survival trait is still necessary to humankind in the present age. We elucidate the benefits on cardiovascular health and kidney disease of RAAS inhibition and present promising novel medications. Furthermore, we address why more studies are needed to establish a new standard of care away from generally prescribing ACEi or ARB toward an improved approach to combine drugs tailored to the needs of individual patients.</jats:p>